Canntab Therapeutics Limited
PILL
Pozycja w akcjach
#40490
Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office... Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office in Markham, Canada, is dedicated to the research and development of sophisticated, medical-grade cannabinoid compounds. The company's diverse portfolio within Canada includes various orally administered pharmaceutical cannabis products. These innovative dosage forms encompass extended-release cannabinoid pellets, rapid-onset cannabidiol options, multi-layered modified-release formulations, quickly dissolving flash-melt versions, and dual-layer cannabinoid tablets. Canntab's products are designed to address a wide spectrum of health concerns, such as sleep disturbances, post-traumatic stress disorder, social anxiety, different forms of addiction, arthritic conditions, general pain management, alleviating pain and stimulating appetite for cancer patients, and aiding in recovery from opioid and other painkiller dependencies.
Cena akcji
$0.0036163
Ostatnia synchronizacja: 2023-10-30
Kapitalizacja rynkowa
$118.21K
Zmiana (1 dzień)
0.39%
Zmiana (1 rok)
3,516.30%
Kraj
CA
Handel Canntab Therapeutics Limited (PILL)
Kategoria
Healthcare
Historia ceny akcji dla Canntab Therapeutics Limited (PILL)
Najwyższa cena zamknięcia: $0.00 dnia 2025-11-01
Najniższa cena zamknięcia: $6.44 dnia 2017-11-01
Najniższa cena zamknięcia: $6.44 dnia 2017-11-01
Historia cen akcji firmy Canntab Therapeutics Limited od 2017 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2026 (TTM) | 0.00% |
| 2025 | 0.00% |
| 2024 | -98.51% |
| 2023 | -50.94% |
| 2022 | -97.46% |
| 2021 | -12.65% |
| 2020 | 80.79% |
| 2019 | -53.66% |
| 2018 | -94.67% |
| 2017 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 21.02% |
DE
|
|
| $41.46 | 47.41% |
JP
|
|
| $212.49 | 23.19% |
CH
|
|
| $19.19 | -0.09% |
IN
|
